Antioxidant properties in laboratory tests
Petunidin shows strong antioxidant activity in lab studies, donating hydrogen atoms to neutralise reactive molecules. Computational analysis found a low bond dissociation energy at its C3 position, indicating high antioxidant capacity. These are laboratory measurements and do not directly translate to benefits from food-additive levels in humans.
Computational modelling found petunidin acts primarily via hydrogen atom transfer, with a bond dissociation energy of 78.72 kcal/mol in gas phase, suggesting strong antioxidant capacity at the molecular level.
2020LabAlam et al., PMC7181340, Food and Chemical Toxicology
A comprehensive food colour review noted that while anthocyanins show antioxidant properties in laboratory conditions, there is no established evidence of antioxidant effects in humans from food-level consumption, including protection of DNA or lipids from oxidative damage.
2022LabPMC8834239, Foods
Cancer cell research in laboratory and animal studies
Petunidin has been tested against cancer cell lines in laboratory conditions, showing antiproliferative and cell-death-inducing effects. Animal studies have shown tumour-related responses. The authors of these reviews consistently flag that long-term human clinical trials are absent, so laboratory findings have not been confirmed in people at food-use levels.
In laboratory studies on glioblastoma cells, petunidin induced cell death via SIRT3/p53 and PI3K/AKT/ERK pathways. Breast and lung cancer cell lines showed G2/M cell cycle arrest and stimulated apoptosis.
2024LabPMC11428540, Nutrients
A systematic review of anthocyanin anticancer research concluded that human clinical trial evidence is 'notably sparse' and long-term trials are a critical research gap, meaning in vitro findings cannot yet be extrapolated to real-world food consumption.
2024Lab + animalPMC11428540, Nutrients
Bioavailability: low absorption in the gut
Petunidin and its glycosides are not efficiently absorbed in the human gut. In a Caco-2 cell model (a standard proxy for human intestinal absorption), petunidin-3-glucoside was among the least-absorbed anthocyanins tested, with negligible transport to the bloodstream side. Most is broken down by gut bacteria or excreted.
In a Caco-2 intestinal cell model, only malvidin-3-glucoside was detected at the bloodstream side; petunidin-3-glucoside showed negligible basolateral transport, indicating very low intestinal absorption.
2025LabPMC12248599, Nutrients
In rat models, glycosylated petunidin was among the least efficiently absorbed anthocyanins compared with delphinidin glycosides, supporting the pattern of low gut bioavailability for this compound.
2022AnimalPetunidin: Advances on Resources, Biosynthesis Pathway, Bioavailability, Bioactivity, and Pharmacology, Springer
EFSA re-evaluation and the absent ADI
In its 2013 re-evaluation of E163 anthocyanins, EFSA's food additives panel concluded the toxicology database was inadequate to set a numerical acceptable daily intake. Long-term chronic toxicity, carcinogenicity, and reproductive studies were described as extremely limited. EFSA noted that exposures from current permitted uses were unlikely to raise safety concerns, while calling for better characterisation and new toxicological data.
EFSA's ANS Panel concluded the toxicological database for anthocyanins (E163) was inadequate to establish a numerical ADI; long-term chronic toxicity, carcinogenicity, and reproductive function studies are extremely limited.
2013Regulatory reviewEFSA ANS Panel, EFSA Journal 11(4):3145
EFSA stated that, despite the data gap, exposures estimated from current approved uses of grape skin extract and blackcurrant extract were unlikely to be of safety concern, and recommended appropriate characterisation and new toxicological data to support future re-evaluation.
2013Regulatory reviewEFSA ANS Panel, EFSA Journal 11(4):3145